# Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

> **NCT04724720** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Northwell Health** · enrollment: 56 (actual)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** Famotidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04724720
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-01-19
- **Primary completion:** 2021-05-03
- **Final completion:** 2022-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2022-04-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04724720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04724720, "Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04724720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*